Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Anectine (succinylcholine)
- digoxin
Interactions between your drugs
digoxin succinylcholine
Applies to: digoxin, Anectine (succinylcholine)
MONITOR: Limited data indicate that the risk of new cardiac arrhythmias is greater when digoxin is given with some depolarizing and nondepolarizing muscle relaxants than when the muscle relaxants are given alone. The mechanism is unknown.
MANAGEMENT: Continuous cardiac monitoring is recommended during coadministration.
References (1)
- (2001) "Product Information. Lanoxin (digoxin)." Glaxo Wellcome
Drug and food interactions
digoxin food
Applies to: digoxin
Administration of digoxin with a high-fiber meal has been shown to decrease its bioavailability by almost 20%. Fiber can sequester up to 45% of the drug when given orally. Patients should be advised to maintain a regular diet without significant fluctuation in fiber intake while digoxin is being titrated.
Grapefruit juice may modestly increase the plasma concentrations of digoxin. The mechanism is increased absorption of digoxin due to mild inhibition of intestinal P-glycoprotein by certain compounds present in grapefruits. In 12 healthy volunteers, administration of grapefruit juice with and 30 minutes before, as well as 3.5, 7.5, and 11.5 hours after a single digoxin dose (0.5 mg) increased the mean area under the plasma concentration-time curve (AUC) of digoxin by just 9% compared to administration with water. Moreover, P-glycoprotein genetic polymorphism does not appear to influence the magnitude of the effects of grapefruit juice on digoxin. Thus, the interaction is unlikely to be of clinical significance.
References (2)
- Darcy PF (1995) "Nutrient-drug interactions." Adverse Drug React Toxicol Rev, 14, p. 233-54
- Becquemont L, Verstuyft C, Kerb R, et al. (2001) "Effect of grapefruit juice on digoxin pharmacokinetics in humans." Clin Pharmacol Ther, 70, p. 311-6
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Diprivan
Diprivan is an intravenous sedative used for general anesthesia and to sedate patients on ...
Levsin
Levsin is used to treat stomach problems such as cramps and irritable bowel syndrome and conditions ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Duragesic
Duragesic skin patch is used to treat moderate to severe chronic pain. Learn about side effects ...
Stadol
Stadol is used for anesthesia, anesthetic adjunct, labor pain, pain
Hyosyne
Hyosyne is used for anticholinesterase poisoning, diverticulitis, irritable bowel syndrome ...
Emla
Emla (lidocaine and prilocaine) is a cream used to numb the skin in preparation for medical ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.